Evaluation with ultrasound on the bedside in serious patients with COVID-19

Not Applicable

Recruiting

• Conditions: Severe Acute Respiratory Syndrome; Coronavirus infections; C01.748.730; C01.925.782.600.550.200

• Registration Number: RBR-43hbks
• Lead Sponsor: Disciplina de Cirurgia Vascular e Endovascular da Universidade Federal de São Paulo

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2020-06-03
• Last Update Posted: 29 May 2023

Recruitment & Eligibility

• Status: Recruiting
• Sex: Not specified
• Target Recruitment: Not specified

Inclusion Criteria

patients admitted to the intensive care unit with a confirmed Covid-19 diagnosis

Exclusion Criteria

covid-19 suspect patient (not yet confirmed)

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
It is expected to find new sites for the passage of central venous access for critically ill patients with COVID 19. It is intended to present the number and possible parameters for central venous access in pronated patients.

Secondary Outcome Measures

Name	Time	Method
It is intended to assess the prevalence of deep venous thrombosis (%), using B-mode ultrasound at the bedside (point-of-care).